Quincy Bioscience Celebrates 5th Birthday of Prevagen
Madison, Wis -- (September 25, 2012) Quincy Bioscience, the makers of the best-selling brain vitamin, celebrate the fifth birthday of Prevagen® during the month of September . To mark the occasion, they are offering a free bottle of Prevagen for people who test their memory at www.FreeOnlineMemoryTest.com.
Quincy Bioscience began in 2004 with break-through technology in a calcium-binding protein, called "apoaequorin," originally discovered in a jellyfish, which is used as a means of helping regulate cellular calcium levels in the nervous system. Voted as one of Business Week’s “Top 100 Companies to Watch” in June of 2006, the company proved apoaequorin to be effective in improving cognitive health, especially for those over the age of 40. Prevagen was first made available in the market direct to consumers in September of 2007.
After successful smaller studies, Quincy Bioscience completed a landmark trial called the Madison Memory Study, in which a total of 218 adults, aged 40 to 91 years, were studied to see if apoaequorin made a difference in certain memory tests. Prevagen, vitamin for the brain, proved effective at improving short-term memory, word recall, and executive function in that study.
One customer that began in the Madison Memory Study, and decided to purchase Prevagen for years after, says “It’s been years for me (on Prevagen)… I had been seeing slips of memory. It was more serious forgetfulness. It took a few months to notice, but I wasn’t forgetting that I had appointments or that people who depended on me could depend. Not having to apologize for a slip in memory is quite a blessing”, says Lise Skofronick, a long-time customer of Prevagen.
Through the dedication and support of thousands of people around the nation, Prevagen recently became the #1 best-selling memory supplement in its class, as reported by A.C. Nielsen.
“By making Prevagen available on the market and promoting better brain health, we’re tackling the problems that we all face related to cognition head on,” says Mark Underwood, President and co-Founder of Quincy Bioscience. “People have an outlet now for improvement and realize that overall health really starts with the brain.”
To learn more about Prevagen and the valuable apoaequorin research by Quincy Bioscience, please visit www.prevagen.com.
About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin focused on the discovery and development of novel compounds to improve cognitive performance and therapeutics to treat age related memory loss and diseases of aging. The company’s technology focuses on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience was recently ranked #398 on the Inc. 500 list of fastest growing private companies in America.
Media Contact:
Todd Olson
(608) 827-8134
tolson@quincybioscience.com
Tags: